Investment Summary

Kingsway Pharmaceuticals Invests In CIGA

On November 17, 2025, Kingsway Pharmaceuticals invested in medical products company CIGA

Investment Highlights
  • This is Kingsway Pharmaceuticals’ 1st transaction in the Medical Products sector.
  • This is Kingsway Pharmaceuticals’ 1st transaction in the United Kingdom.

Investment Summary

Date 2025-11-17
Target CIGA
Sector Medical Products
Investor(s) Kingsway Pharmaceuticals
Deal Type Stake Purchase

Target

CIGA

Ballymena, United Kingdom
CIGA designs and manufactures over-the-counter, professional and veterinary rapid diagnostic tests, supplying pharmacies, health services and global distribution partners. CIGA was founded in 2005 and is headquartered in Ballymena, United Kingdom.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Kingsway Pharmaceuticals

Bristol, Tennessee, United States

Category Company
Sector Medical Products
DESCRIPTION

Kingsway Pharmaceuticals is a company offering consumer-health solutions, including over-the-counter products, diagnostics and topical creams, and also provides private label manufacturing services for beauty, OTC and veterinary diagnostics. Kingsway Pharmaceuticals is based in Bristol, Tennessee.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2025 M&A 1 of 1